KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Assets Average (2016 - 2025)

Pacira BioSciences (PCRX) has 15 years of Assets Average data on record, last reported at $1.3 billion in Q4 2025.

  • For Q4 2025, Assets Average fell 16.67% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, down 16.67%, while the annual FY2025 figure was $1.4 billion, 9.89% down from the prior year.
  • Assets Average reached $1.3 billion in Q4 2025 per PCRX's latest filing, down from $1.4 billion in the prior quarter.
  • Across five years, Assets Average topped out at $2.0 billion in Q1 2022 and bottomed at $1.3 billion in Q1 2021.
  • Average Assets Average over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2025.
  • Peak YoY movement for Assets Average: surged 55.05% in 2021, then fell 19.21% in 2023.
  • A 5-year view of Assets Average shows it stood at $1.7 billion in 2021, then dropped by 0.46% to $1.7 billion in 2022, then decreased by 8.98% to $1.6 billion in 2023, then dropped by 1.08% to $1.5 billion in 2024, then dropped by 16.67% to $1.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $1.3 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.6 billion in Q2 2025.